Please login to the form below

Not currently logged in
Email:
Password:

compulsory licence

This page shows the latest compulsory licence news and features for those working in and with pharma, biotech and healthcare.

Bayer fails to overturn Nexavar compulsory licence in India

Bayer fails to overturn Nexavar compulsory licence in India

Bayer fails to overturn Nexavar compulsory licence in India. Natco Pharma allowed to sell cut-price version of cancer drug. ... Natco received the the compulsory licence in March 2012 on the grounds that Bayer had not made the drug available at a

Latest news

  • India's patents versus India's patients India's patents versus India's patients

    Alternatively, we might see more examples of compulsory licensing in India where a government allows a third party to produce a patented product without the consent of the patent owner. ... In a landmark decision earlier this year, India granted its

  • India could hit Roche and BMS with compulsory licences India could hit Roche and BMS with compulsory licences

    India could hit Roche and BMS with compulsory licences. Generic versions of Herceptin, Sprycel and Ixempra may reach market before patent expiration. ... The first compulsory licence in India was introduced last year for Bayer's liver cancer drug Nexevar

  • Indonesia breaks seven HIV, hepatitis drug patents Indonesia breaks seven HIV, hepatitis drug patents

    The government of Indonesia issued compulsory licences for seven drugs used to treat HIV and hepatitis B last month, clearing the way for generic competitors to reach the market. ... The drugs covered by the compulsory licence include Merck &Co's Stocrin

  • Bayer fails to block Indian Nexavar compulsory licence Bayer fails to block Indian Nexavar compulsory licence

    Bayer fails to block Indian Nexavar compulsory licence. Loses ‘ stay’ appeal against Natco Pharma in Chennai court. ... The Intellectual Property Appellate Board of Chennai upheld the compulsory licence that was granted to Indian firm Natco Pharma by

  • Chinese compulsory licensing law comes into effect Chinese compulsory licensing law comes into effect

    Earlier this year Bayer's cancer drug Nexavar (sorenfinib) was hit by a compulsory licence in India, the first time one has been used in that country. ... The patent office, which describes a compulsory licence as an "involuntary contract between a

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Intellectual property threats in the BRIC markets Intellectual property threats in the BRIC markets

    Brazil, for example, used the threat of compulsory licensing to obtain discounts for various HIV drugs, before actually issuing a compulsory licence in 2007 for Stocrin. ... of the compulsory licence process for Herceptin, Sprycel and Ixempra,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics